EUVIMED · CrossrefJournal
Haematologica
ISSN 0390-6078 · Ferrata Storti Foundation (Haematologica)
Latest articles
Integrating information across datasets to improve prognostic models for patients with diffuse large B-cell lymphoma
Short and long-term mental and functional disorders in young adult Hodgkin lymphoma survivors
The preanalytical phase in hematopathology: sampling as a critical step for an appropriate diagnosis. A position paper from the Italian Group of Haematopathology (GIE)
Allogeneic hematopoietic stem cell transplantation after CD19-directed CAR T-cell therapy in children and adults with B-cell acute lymphoblastic leukemia: a GoCART coalition study on behalf of the PDWP, ALWP, and CTIWP of the EBMT
Severe and fatal central nervous system toxicity after fludarabine, thiotepa and melphalan conditioning for allogeneic stem cell transplantation
Characterization and impact of response to holding/bridging therapy in second-line large Bcell lymphoma patients treated with axicabtagene ciloleucel: a LYSA study from the French DESCAR-T registry
Outcomes associated with CD3xCD20 bispecific antibody therapies in relapsed/refractory transformed indolent lymphoma
Reduced intensity hematopoietic cell transplant using best available donor and posttransplant cyclophosphamide is safe and curative for transfusion-dependent thalassemia
Whole-blood RNA-seq facilitates splice variant classification in platelet disorders
Steroid-refractory ICANS after CAR T-cell therapy: the case for prospective evidence. Comment on: "Relapsing, steroid-refractory ICANS after CAR T-cell therapy: diagnostic work-up and response to delayed repeated intrathecal chemotherapy"
Preserving liposomal anthracycline exposure and reconsidering radiotherapy in frontline therapy of older adults with advanced-stage classical Hodgkin lymphoma. Comment on: “Nivolumab with doxorubicin, vinblastine, and dacarbazine in older adults with classic Hodgkin lymphoma: do S1826 results hold up in the real world?”
Comment on: “Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumab”
Onset-subtype-dependent diagnostic performance of serum hyaluronic acid for sinusoidal obstruction syndrome/veno-occlusive disease after allogeneic hematopoietic cell transplantation
Intercellular transfer of FOLR2 from nurse-like cells fuels chronic lymphocytic leukemia cell activation and proliferation
Clonal hematopoiesis in long-term survivors after allogeneic hematopoietic cell transplantation: associations with active chronic graft-versus-host disease, donor age, and transplantation for chronic myeloid leukemia
Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome
Transcriptional landscape of nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma: tumor microenvironment and checkpoint genes
Rapid identification of the high-risk IGLV3-21R110 subgroup of chronic lymphocytic leukemia by flow cytometry
ICOS/ICOSL coexpression in Sézary syndrome reveals a potential tumorpromoting T-cell interaction
Teclistamab in multiple myeloma with coexisting myelodysplastic syndrome or acute myeloid leukemia
Paraneoplastic spongiotic dermatitis associated with progression to treatment-requiring chronic lymphocytic leukemia
Glucagon-like peptide-1 receptor agonist exposure is associated with lower secondary malignancy risk during watch-and-wait in chronic lymphocytic leukemia: a timevarying analysis
Response to comment on: “Immune checkpoint therapy in pediatric and adolescent lymphomas”.
Response to Comment on: “Risk factors and their contributions to prognosis in multiple myeloma”
Response to Comment on: “Avatrombopag as a novel salvage therapy for refractory thrombocytopenia in THPO-mutated congenital amegakaryocytic thrombocytopenia after allogeneic hematopoietic stem cell transplantation”
Blasting high-burden T-large granular lymphocytic leukemia with bendamustine
Monoclonal gammopathy-related thrombocytopenia. Comment on: “Diagnostic and therapeutic challenges in rare hematologic entities: monoclonal gammopathy of thrombotic and bleeding significance”
Functional DNase assessment in posttransplant lung injury. Comment on: "Neutrophil extracellular traps and DNase I levels in the bronchoalveolar lavage fluid of children with pulmonary injury after allogeneic hematopoietic stem cell transplantation: a TRANSPIRE study"
Response to Comment on: “Carbon footprint of direct oral anticoagulants in atrial fibrillation and venous thromboembolism”
Prospective study of longitudinal geriatric assessment with risk-adapted interventions for older patients in allogeneic hematopoietic cell transplantation
EUVIMED